Akcea Therapeutics, Inc.

Q2 2020 13F Holders

Symbol
AKCA
CUSIP
00972L107
Type
Equity
Class
COM
Num filings
92
Total reported value, excl. options
$268 M
Manager Report Date Value ($000) Shares Option Type